FDA rejects Chinese cancer drugs
The United States Food and Drug Administration (FDA) on Monday declined to approve two proposed new cancer drugs that were developed in…
Read more
Established in 2017, H2 Global Group (乐康天下) is an integrated Consultancy, Technology Solution Provider and Medical Supplies Distributor with offices in China, Hong Kong SAR, Malaysia, Singapore and Thailand.
We are practitioners and also entrepreneurs. Through our Actionable Strategy approach and wide distribution network, we have become a trusted advisor to many leading companies and manufacturers around the world, particularly for those who want to secure their presence in Southeast Asia and Greater China region.
